spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

BioProcess International Conference & Exhibition (BPI)

BioProcess International Conference & Exhibition (BPI)

25-28 September 2017
Hynes Convention Center, Boston, Massachusetts, USA

BioProcess International Conference & Exhibition (BPI) is the largest bioprocessing event bringing you the science, technologies and partners needed to accelerate promising biologics towards commercial success.  Join 1800+ global bioprocessing professionals at this year’s meeting, held September 25-28, 2017 at the Hynes Convention Center in Boston.  The 2017 scientific agenda covers important industry updates and new data across entire bioprocessing spectrum, from early stage process development through late stage commercial manufacturing.  We are pleased to announce the confirmation of our first two keynote speakers:

  • Improving Global Access to Biotherapeutics through Molecule, Process and Manufacturing Design: Dean K. Pettit, Ph.D., CSO and Founding Partner, Just Biotherapeutics
  • Tools for Mapping and Repairing Disease States: Can We Make Therapeutic Invention into a Mature Design Science?: Ed Boyden, Ph.D., Associate Professor, Media Lab and McGovern Institute, MIT

Readers of European Biopharmaceutical Review can receive a 10% registration discount off current rates by registering with VIP code EBR10 online at http://bit.ly/samedanEBR (new registrations only).  If you have any questions about participating at this year’s meeting, please contact Event Marketing Manager Howie Choi at howard.choi@knect365.com.

email Howie Choi: howard.choi@knect365.com
web bit.ly/samedanEBR
email Hynes Convention Center, Boston, Massachusetts, USA
 
Print this page
Send to a friend
   
spacer
Industry Events

7th annual Orphan Drugs and Rare Diseases UK

18-19 October 2017, Holiday Inn Kensington Forum, London

SMi Group is thrilled to present the 7th annual Orphan Drugs and Rare Diseases conference, taking place on 18th & 19th October 2017 in Central London, UK. This year’s theme will be focused towards discussing strategies for patient engagement, market access and gene therapies to enhance rare diseases and orphan drug research.
More info >>

White Papers

The Role of the CRO in Effective Risk-Based Monitoring

Medpace

The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging trial sponsors to transition from a focused on-site monitoring approach they have traditionally employed toward a risk-based approach that utilizes a combination of centralized and on-site monitoring techniques to ensure patient safety and data quality. The Risk-Based Monitoring (RBM) paradigm has many potential advantages over established monitoring practices including enhanced patient safety and data integrity, more efficient and effective protocol design, reduced costs, and the ability to strategically adjust oversight in keeping with changes in risk level.
More info >>


News and Press Releases

Top Research University Enjoys Easy-to-Use Software to Support Enterprise-wide Temperature Monitoring, Alarming and Reporting


More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement